PW-RT 60mg Peptide

PW-RT 60mg Peptide. Retatrutide is a next-generation metabolic research compound studied across GLP-1, GIP, and glucagon receptor pathway models.

Its triple-pathway profile makes it a standout in research focused on appetite signaling, energy balance, glucose regulation, and metabolic adaptation. Advanced metabolic research with a wider lens.

Three pathways. One high-impact research framework.

Reta 60mg – 3ml Small Vial

Retatrutide is a synthetic research peptide characterized as an agonist at the glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors. This product is listed as 60 mg in a 3 mL vial configuration and is intended for controlled laboratory and analytical research only.

Research Focus

• Receptor pharmacology involving GIP, GLP-1, and glucagon receptor systems
• Comparative multi-receptor agonism and signal-transduction studies
• Analytical characterization and controlled in vitro research workflows

Product Details

• Listed Content: 60 mg
• Vial Configuration: 3 mL vial
• Research Category: Multi-receptor peptide research
• Purity: Refer to the lot-specific Certificate of Analysis
• Use Classification: Laboratory research only

Handling and Documentation

Use appropriate laboratory controls and handling procedures. Confirm identity, purity, storage conditions, and other lot-specific specifications against the applicable product label and Certificate of Analysis before experimental use. Do not infer specifications that are not stated in the lot documentation.

Research Use Restriction

For research use only. Not for human or veterinary use, consumption, compounding, diagnosis, treatment, prevention of disease, or any household or personal-use application. No dosing, administration, or therapeutic-use instructions are provided.

Research References

• https://pubmed.ncbi.nlm.nih.gov/37385280/
• https://pubmed.ncbi.nlm.nih.gov/42250575/

ORDER NOW